[Federal Register: August 22, 2005 (Volume 70, Number 161)]
[Notices]
[Page 48980]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22au05-107]
[[Page 48980]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on October 25, 2004, Navinta
LLC, 1499 Lower Ferry Road, Ewing, New Jersey 08616-1414, made
application to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic class of controlled
substances listed in Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Fentanyl (9801)............................................ II
Sufentanil (9740).......................................... II
------------------------------------------------------------------------
The company plans to bulk manufacture the controlled substances for
product development of generic and brand pharmaceutical products.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than October 21, 2005.
Dated: August 15, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-16567 Filed 8-19-05; 8:45 am]
BILLING CODE 4410-09-P